アステラス製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2018/12/27 | 1,428 | 1,455.5 | 1,412.5 | 1,442 | +48.5 | +3.5% | 6,160,900 |
2018/12/26 | 1,388 | 1,407 | 1,368 | 1,393.5 | +19 | +1.4% | 6,058,200 |
2018/12/25 | 1,435.5 | 1,437 | 1,372 | 1,374.5 | -87.5 | -6% | 6,777,000 |
2018/12/21 | 1,464 | 1,490.5 | 1,459 | 1,462 | -13 | -0.9% | 10,700,400 |
2018/12/20 | 1,508.5 | 1,523 | 1,471 | 1,475 | -31 | -2.1% | 8,337,500 |
2018/12/19 | 1,528.5 | 1,544 | 1,502 | 1,506 | -48.5 | -3.1% | 7,874,000 |
2018/12/18 | 1,652.5 | 1,656 | 1,549.5 | 1,554.5 | -106 | -6.4% | 9,457,100 |
2018/12/17 | 1,654.5 | 1,668.5 | 1,644.5 | 1,660.5 | +4.5 | +0.3% | 3,710,200 |
2018/12/14 | 1,690.5 | 1,716 | 1,655.5 | 1,656 | -34.5 | -2% | 10,216,400 |
2018/12/13 | 1,688 | 1,710.5 | 1,679.5 | 1,690.5 | +30.5 | +1.8% | 6,122,900 |
2018/12/12 | 1,669.5 | 1,674 | 1,646 | 1,660 | +20.5 | +1.3% | 8,063,100 |
2018/12/11 | 1,661.5 | 1,665.5 | 1,639 | 1,639.5 | -8 | -0.5% | 5,270,200 |
2018/12/10 | 1,656 | 1,668 | 1,637.5 | 1,647.5 | -35 | -2.1% | 4,523,200 |
2018/12/07 | 1,720 | 1,720 | 1,664.5 | 1,682.5 | +28.5 | +1.7% | 6,153,800 |
2018/12/06 | 1,676.5 | 1,690.5 | 1,644 | 1,654 | -39 | -2.3% | 6,129,800 |
2018/12/05 | 1,649 | 1,699 | 1,639 | 1,693 | -9 | -0.5% | 5,144,700 |
2018/12/04 | 1,753 | 1,759.5 | 1,700.5 | 1,702 | -61.5 | -3.5% | 6,210,600 |
2018/12/03 | 1,773 | 1,793 | 1,757.5 | 1,763.5 | +19 | +1.1% | 6,265,900 |
2018/11/30 | 1,719.5 | 1,752 | 1,706 | 1,744.5 | +32.5 | +1.9% | 13,886,800 |
2018/11/29 | 1,686.5 | 1,713.5 | 1,684.5 | 1,712 | +39 | +2.3% | 5,681,500 |
2018/11/28 | 1,665 | 1,680 | 1,651 | 1,673 | +18.5 | +1.1% | 4,494,900 |
2018/11/27 | 1,690 | 1,693 | 1,647.5 | 1,654.5 | -36 | -2.1% | 7,053,500 |
2018/11/26 | 1,694 | 1,695.5 | 1,668 | 1,690.5 | -8.5 | -0.5% | 6,695,200 |
2018/11/22 | 1,698.5 | 1,702.5 | 1,672.5 | 1,699 | +40.5 | +2.4% | 4,776,100 |
2018/11/21 | 1,640 | 1,665 | 1,637 | 1,658.5 | -2.5 | -0.2% | 4,643,800 |
2018/11/20 | 1,700.5 | 1,713 | 1,660.5 | 1,661 | -48 | -2.8% | 4,940,500 |
2018/11/19 | 1,678 | 1,711.5 | 1,676.5 | 1,709 | +45 | +2.7% | 4,299,800 |
2018/11/16 | 1,682.5 | 1,687 | 1,661 | 1,664 | +2.5 | +0.2% | 3,449,800 |
2018/11/15 | 1,670 | 1,681 | 1,655.5 | 1,661.5 | -28.5 | -1.7% | 3,926,700 |
2018/11/14 | 1,718.5 | 1,736 | 1,683 | 1,690 | +11 | +0.7% | 5,492,200 |
2018/11/13 | 1,685 | 1,690.5 | 1,651.5 | 1,679 | -33 | -1.9% | 5,189,600 |
2018/11/12 | 1,690 | 1,724.5 | 1,688 | 1,712 | +8 | +0.5% | 3,843,600 |
2018/11/09 | 1,715 | 1,754.5 | 1,704 | 1,704 | -7.5 | -0.4% | 6,343,100 |
2018/11/08 | 1,704 | 1,726 | 1,694 | 1,711.5 | +33 | +2% | 6,856,700 |
2018/11/07 | 1,714 | 1,732.5 | 1,671 | 1,678.5 | -58 | -3.3% | 7,194,100 |
2018/11/06 | 1,698 | 1,736.5 | 1,697 | 1,736.5 | +61.5 | +3.7% | 6,113,600 |
2018/11/05 | 1,732 | 1,736.5 | 1,673.5 | 1,675 | -56 | -3.2% | 7,338,100 |
2018/11/02 | 1,682 | 1,736 | 1,674 | 1,731 | +76 | +4.6% | 9,679,600 |
2018/11/01 | 1,758 | 1,759.5 | 1,647 | 1,655 | -92 | -5.3% | 6,408,900 |
2018/10/31 | 1,759 | 1,764 | 1,717 | 1,747 | +16 | +0.9% | 7,587,000 |
2018/10/30 | 1,702 | 1,731 | 1,698.5 | 1,731 | +26.5 | +1.6% | 12,754,600 |
2018/10/29 | 1,741.5 | 1,748.5 | 1,704.5 | 1,704.5 | -40 | -2.3% | 5,782,900 |
2018/10/26 | 1,755 | 1,757 | 1,722 | 1,744.5 | +29.5 | +1.7% | 8,836,400 |
2018/10/25 | 1,780 | 1,786 | 1,709 | 1,715 | -99.5 | -5.5% | 8,068,200 |
2018/10/24 | 1,829 | 1,840.5 | 1,787.5 | 1,814.5 | +14.5 | +0.8% | 7,038,500 |
2018/10/23 | 1,848.5 | 1,850 | 1,796 | 1,800 | -60.5 | -3.3% | 6,976,600 |
2018/10/22 | 1,864.5 | 1,873.5 | 1,839 | 1,860.5 | -28 | -1.5% | 4,514,200 |
2018/10/19 | 1,856.5 | 1,891.5 | 1,852 | 1,888.5 | +19 | +1% | 4,262,300 |
2018/10/18 | 1,883 | 1,887 | 1,861 | 1,869.5 | +4.5 | +0.2% | 4,823,400 |
2018/10/17 | 1,877.5 | 1,882.5 | 1,854 | 1,865 | +8.5 | +0.5% | 4,898,500 |
1551~
1600
件表示中 / 3697件
類似銘柄と比較する
現在ご覧いただいている「アステラス薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
アステラス薬 | 137,200円 | +0.9% | +380.2% | 5.69% | 18.90倍 | 1.62倍 |
|
医薬品国内2位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
武 田 | 411,300円 | -1.1% | +75.3% | 4.86% | 28.18倍 | 0.93倍 |
|
国内製薬首位。がん、中枢神経、消化器、希少疾患等に重点。巨額買収で世界売上上位10強入り |
大塚HD | 684,500円 | +2.2% | +10.2% | 1.75% | 13.15倍 | 1.32倍 |
|
国内製薬大手で抗精神病薬が主力。ポカリスエットなど機能性食品も拡大。世界90カ所に工場 |
塩野義 | 223,100円 | +20.9% | +10.6% | 2.96% | 10.55倍 | 1.39倍 |
|
抗HIV薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
エーザイ | 399,900円 | +1.7% | -2.9% | 4.00% | 26.24倍 | 1.38倍 |
|
神経系、がん領域に強み。認知症薬は米バイオジェンと、抗がん薬では米メルクと国際協業推進 |
市場注目の銘柄
チャート関連のコラム